Container Top
Search

Events Calendar

EVENT SEARCH:

In This Section


Most Read Stories


Blogs:


First Bell - On Education:
No City of Akron basketball tonight

Pets:
Pet telethon re-airs

The Heldenfiles:
Chipmunks "Squeakquel" on DVD/BD March 30

Akron Zips:
Late surge gives Zips ugly road win

Tribe Matters:
Blogmail response on Hafner

Cleveland Browns:
Stallworth's contract terminated

Balanced Ledger:
QB in Browns future: another mock draft

Kent State Sports:
KSU Notes – February 9

Cleveland Cavaliers:
NBA Power Rankings from Around the Internet

Buckeye Blogging:
Buckeyes grab 18 players on signing day

Varsity Letters:
Garfield at Buchtel basketball

All Da King's Men:
Palin At The Tea Party Convention

Blog of Mass Destruction:
Republican Pre-Conditions

Akron Law Café:
Citizens United v. F.E.C. (Part 4): Kennedy's and O'Connor's Basic Approaches to Constitutional Decisionmaking – Top Down and Bottom Up

Car Chase:
Collector Car Hobby Loses One of the Best—Jim Roll

Let's Talk Real Estate:
Decisions Decisions: Credit Cards or Your Mortgage?

Ohio Travels with Betty:
Loucile is looking for a Lake Erie getaway in June for three kids, ages 1, 3, and 5.

Sound Check:
Talk of the Town – Top entertainment picks for the weekend

HRLite House:
Track HR Research

Akron Gamer:
Makers of 'Castle Crashers' unveil 'BattleBlock Theater'

See Jane Style:
Do IT this week: Layering

FDA says Prilosec can block benefits of Plavix

By Matthew Perrone
Associated Press

WASHINGTON: Federal health officials said today a popular heartburn medication can interfere with the blood thinner Plavix, a drug taken by millions of Americans to reduce risks of heart attack and stroke.

The Food and Drug Administration said the stomach-soothing drug Prilosec cuts the blood-thinning effect of Plavix by half.

Regulators said the key ingredient in Procter & Gamble's Prilosec blocks Plavix, known generically as clopidogrel, from taking full effect.

''Patients at risk for heart attacks or strokes who use clopidogrel to prevent blood clots will not get the full effect of this medicine,'' the agency said in a statement.

Plavix is marketed by Sanofi-Aventis and Bristol-Myers Squibb. With global sales of $8.6 billion last year, it's the world's second-best selling drug behind Pfizer's cholesterol drug Lipitor.

Because Plavix can upset the stomach, it is often prescribed with stomach acid-blocking drugs.

The FDA says patients who need to reduce their acid should take alternative drugs like Johnson & Johnson's Mylanta or Boehringer Ingelheim's Zantac.

Information about the drug interaction between Plavix and certain heartburn medications is not new. In January, Sanofi and Bristol-Myers updated Plavix's labeling to advise against using it in combination with certain heartburn drugs, following medical journal articles about the negative interaction.

A Sanofi spokeswoman said the company has now bolstered that labeling.

''We've strengthened the label to say that these drugs should be avoided altogether, not just discouraged,'' said Noelle Boyd, Sanofi's senior communications director.

WASHINGTON: Federal health officials said today a popular heartburn medication can interfere with the blood thinner Plavix, a drug taken by millions of Americans to reduce risks of heart attack and stroke.

The Food and Drug Administration said the stomach-soothing drug Prilosec cuts the blood-thinning effect of Plavix by half.

Regulators said the key ingredient in Procter & Gamble's Prilosec blocks Plavix, known generically as clopidogrel, from taking full effect.

''Patients at risk for heart attacks or strokes who use clopidogrel to prevent blood clots will not get the full effect of this medicine,'' the agency said in a statement.

Plavix is marketed by Sanofi-Aventis and Bristol-Myers Squibb. With global sales of $8.6 billion last year, it's the world's second-best selling drug behind Pfizer's cholesterol drug Lipitor.

Because Plavix can upset the stomach, it is often prescribed with stomach acid-blocking drugs.

The FDA says patients who need to reduce their acid should take alternative drugs like Johnson & Johnson's Mylanta or Boehringer Ingelheim's Zantac.

Information about the drug interaction between Plavix and certain heartburn medications is not new. In January, Sanofi and Bristol-Myers updated Plavix's labeling to advise against using it in combination with certain heartburn drugs, following medical journal articles about the negative interaction.

A Sanofi spokeswoman said the company has now bolstered that labeling.

''We've strengthened the label to say that these drugs should be avoided altogether, not just discouraged,'' said Noelle Boyd, Sanofi's senior communications director.



Story tools

Email  Email   Print  Print   Save  Save   Reprint  Reprint   Popular  Most Popular   Reprint  Subscribe

Share this story

AddThis Social Bookmark Button














Most Commented Stories